Aemetis (NASDAQ:AMTX) Raised to “Sell” at StockNews.com

StockNews.com upgraded shares of Aemetis (NASDAQ:AMTX) to a sell rating in a report issued on Wednesday.

Separately, HC Wainwright reaffirmed a “buy” rating and issued a $28.00 price target on shares of Aemetis in a report on Monday, December 23rd. One research analyst has rated the stock with a sell rating, one has issued a hold rating and four have issued a buy rating to the stock. According to data from MarketBeat, the company currently has a consensus rating of “Moderate Buy” and an average target price of $12.95.

Aemetis Stock Performance

Shares of AMTX stock opened at $2.04 on Wednesday. Aemetis has a fifty-two week low of $2.00 and a fifty-two week high of $7.03. The stock’s fifty day moving average is $2.74 and its two-hundred day moving average is $2.84. The firm has a market capitalization of $101.47 million, a P/E ratio of -0.90 and a beta of 1.44.

Aemetis (NASDAQ:AMTX) last posted its quarterly earnings results on Tuesday, November 12th. The specialty chemicals company reported ($0.38) earnings per share for the quarter, topping analysts’ consensus estimates of ($0.47) by $0.09. The business had revenue of $81.44 million for the quarter, compared to analyst estimates of $77.79 million. During the same quarter in the previous year, the firm posted ($0.59) earnings per share. On average, equities analysts forecast that Aemetis will post -2.07 earnings per share for the current year.

Institutional Trading of Aemetis

Institutional investors have recently made changes to their positions in the company. FMR LLC grew its holdings in shares of Aemetis by 68.2% during the 3rd quarter. FMR LLC now owns 22,531 shares of the specialty chemicals company’s stock worth $52,000 after purchasing an additional 9,137 shares during the period. State Street Corp raised its stake in shares of Aemetis by 36.1% in the 3rd quarter. State Street Corp now owns 699,089 shares of the specialty chemicals company’s stock valued at $1,608,000 after acquiring an additional 185,304 shares during the period. Wellington Management Group LLP acquired a new position in shares of Aemetis in the 3rd quarter worth approximately $177,000. Barclays PLC boosted its position in shares of Aemetis by 274.6% during the 3rd quarter. Barclays PLC now owns 47,496 shares of the specialty chemicals company’s stock worth $109,000 after purchasing an additional 34,816 shares during the period. Finally, Geode Capital Management LLC increased its holdings in Aemetis by 7.7% in the 3rd quarter. Geode Capital Management LLC now owns 924,293 shares of the specialty chemicals company’s stock valued at $2,126,000 after purchasing an additional 66,031 shares during the last quarter. Hedge funds and other institutional investors own 27.02% of the company’s stock.

Aemetis Company Profile

Aemetis, Inc operates as a renewable natural gas and renewable fuels company. It operates through three segments: California Ethanol, California Dairy Renewable Natural Gas, and India Biodiesel. The company focuses on the operation, acquisition, development, and commercialization of technologies to produce low and negative carbon intensity renewable fuels that replace fossil-based products.